Company performance
Current Price
as of Jan 20, 2025$3.62
P/E Ratio
N/A
Market Cap
$1.18B
Loading...
Description
CanSino Biologics, Inc. engages in the research and development, manufacturing, and sale of vaccines. It offers shingles, meningitis, polio, adenovirus, and tuberculosis vaccines. The company was founded by Xuan Liu, Xue Feng Yu, Tao Zhu, Dong Xu Qiu and Hui Hua Mao on January 13, 2009 and is headquartered in Tianjin, China.
Metrics
Overview
- HQTianjin, TI
- SectorHealth Technology
- IndustryBiotechnology
- TickerCASBF
- Price$3.623046+0.02%
Trading Information
- Market cap$1.18B
- Float26.85%
- Average Daily Volume (1m)887,473
- Average Daily Volume (3m)1,424,446
- EPS-$3.15
Company
- Revenue$802.00M
- Rev growth (1yr)77.66%
- Net income$3.23M
- Gross margin78.99%
- EBITDA marginN/A
- EBITDAN/A
- EV$5.74B
- EV/Revenue7.15
- P/EN/A
- P/S10.55
- P/B1.28
Documents
Factset Street Account
Factset